Volume 1, Issue 1
Elsevier is honored to publish some of the best and most diverse journals in gastroenterology and hepatology. With partners like the AGA, ASGE and EASL we bring you the latest advances in the field. We also publish high quality specialist journals on the pancreas and on endoscopic techniques. With this our inaugural newsletter and those to follow, we aim to share highlights from across our portfolio. We hope you enjoy our publication.
Follow Elsevier GastroHep on social media:
Elsevier is proud to announce that the International Hepato-Pancreato-Biliary Association (IHPBA) has chosen Elsevier to be the publisher of HPB from January 2016. Elsevier has a strong history of publishing health research in the fields of hepatology and surgery and we are delighted that HPB articles will now add to our most up-to-date research publications and our extensive online archive. HPB was first published by the IHPBA in 1999 and under the current editorial leadership of Professor O. James Garden the journal now has an Impact Factor of 2.675.
With the start of the 2016, Digestive and Liver Disease welcomed a new editorial team. Roberto de Franchis took over as Editor-in-Chief, sharing responsibilities with Co-Editors Savino Bruno and Maurizio Vecchi. As they mention in their first editorial, they will continue to make “every effort to ensure a fair, efficient and rapid handling of your contributions”. The journal is also extremely proud to present a new cover design (shown) and a complete update of the journal website:
Our sincere thanks go out to Mario Angelico and Paola Piccolo, who for 7 years managed the journal very efficiently. Read their editorial farewell here
The concept of a critical “niche” in each of the units of the intestine suggests that there are intrinsic properties within gland crypts that promote and maintain the normal production of cell lineages in the mucosa. A recent article in Cellular and Molecular Gastroenterology and Hepatology demonstrates that mesenchymal cells expressing the transcription factor Foxl1 are the “niche” cell.
GLP-1 Pathway Drugs and the Pancreas
The use of GLP-1 pathway (incretin) drugs for diabetes has caused quite some controversy in the past as the effects on the pancreas were initially not very clear. The current clinical consensus is reassuring, but with increasing use of incretin drugs, pancreatologists are more frequently faced with questions about them. Three reviews published in Pancreatology cover the clinical application of these drugs, the physiology of the GLP-1 pathways, and the current consensus on the effect on the exocrine pancreas:
Eosinophilic esophagitis (EoE) is a chronic allergic/immune-mediated condition of the esophagus. Esophageal biopsy specimens from patients with EoE can feel firm, with resistance felt when pulling the forceps to obtain the tissue sample. Evan S. Dellon and colleagues assessed the diagnostic utility of the esophageal biopsy “pull” sign and determined its histologic associations and response to treatment in this prospective cohort study of 83 patients with EoE and 121 control subjects.
In a second special issue of 2015, the editors of Gastroenterology chose to focus on the topic of genetics, genetic testing, and biomarkers in digestive diseases due to the rapid advances in these areas among GI diseases. The studies highlight how fast information has moved, and how quickly biomarkers and potential therapeutic targets for treatment purposes are lining up for phased human clinical studies, pharmaceutical testing portfolios, and routine patient use.
Full-thickness perforation of the gastrointestinal (GI) tract is one of the most devastating complications of GI endoscopy. For years, fear of this complication prevented many from considering endoscopic resection of tumors arising from the deeper layers of the digestive tract. Many endoscopists find it unfathomable to intentionally transgress the entire wall of the GI tract. However, recent advances in reliable full-thickness endoscopic closure devices have allowed this to become possible in both a safe and effective manner.
In medical practice one is confronted with ethical issues on a regular basis. However, these topics are seldom addressed comprehensively in gastroenterology journals. To change this, the journal Best Practice & Research: Clinical Gastroenterology commissioned a set of review articles addressing clinical questions around such topics as artificial nutrition, stem cells and bariatric surgery as well as public health issues such as drug pricing and research integrity. To draw more attention to these topics and stimulate discussion, the special issue will be freely available through the end of the year.
The first special issue from Clinical Gastroenterology and Hepatology focuses on the clinical management of several hepatic disorders, including common conditions such as nonalcoholic fatty liver disease (NAFLD) and viral hepatitis; and uncommon but difficult disorders such as autoimmune hepatitis and primary sclerosing cholangitis (PSC).
Tell Your Research Story with AudioSlides
The number of published papers worldwide is growing at an accelerating pace. To avoid that your work is missed among the many it becomes more and more important to make your research stand out. In one special way to do this, the Journal of Hepatology makes it possible to attract attention to your article with AudioSlides. These are short, webcast-style presentations, which allow you to present your research in your own words. You can give readers a short and concise overview of your article. The AudioSlides appear alongside the article, are free to view and listen to and can easily be shared on social media.
Following are examples of articles with AudioSlides:
Submit Your Research
We invite you to submit your next article to one of these Elsevier journals.